The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Samoilova A.V.

Ulyanov Chuvash State University

Gunin A.G.

Ulyanov Chuvash State University

Sidorov A.E.

Ulyanov Chuvash State University

Denisova T.G.

Ulyanov Chuvash State University;
Postgraduate Doctors’ Training Institute

Chernyshov V.V.

Ulyanov Chuvash State University

Smirnova T.L.

Ulyanov Chuvash State University

Actual research trends in etiology and pathogenesis of endometriosis (a review)

Authors:

Samoilova A.V., Gunin A.G., Sidorov A.E., Denisova T.G., Chernyshov V.V., Smirnova T.L.

More about the authors

Journal: Russian Journal of Human Reproduction. 2020;26(5): 118‑132

Read: 11307 times


To cite this article:

Samoilova AV, Gunin AG, Sidorov AE, Denisova TG, Chernyshov VV, Smirnova TL. Actual research trends in etiology and pathogenesis of endometriosis (a review). Russian Journal of Human Reproduction. 2020;26(5):118‑132. (In Russ.)
https://doi.org/10.17116/repro202026051118

Recommended articles:
Epidemiology of M. geni­talium infe­ction. What is known?. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):143-152
Pathogenesis of fibrosis deve­lopment in ovarian endo­metriosis. Russian Journal of Archive of Pathology. 2025;(2):73-78
Portopulmonary hype­rtension. Journal of Respiratory Medi­cine. 2025;(2):39-44
Bacterial vagi­nosis: modern views. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):261-268

References:

  1. Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, Heikinheimo O, Horne AW, Kiesel L, Nap A, Prentice A, Saridogan E, Soriano D, Nelen W; European Society of Human Reproduction and Embryology. ESHRE guideline: management of women with endometriosis. Human Reproduction. 2014;29(3):400-412.  https://doi.org/10.1093/humrep/det457
  2. Abbas S, Ihle P, Koster I, Schubert I. Prevalence and incidence of diagnosed endometriosis and risk of endometriosis in patients with endometriosis-related symptoms: findings from a statutory health insurance-based cohort in Germany. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2012;160(1):79-83.  https://doi.org/10.1016/j.ejogrb.2011.09.041
  3. Janssen EB, Rijkers AC, Hoppenbrouwers K, Meuleman C, D’Hooghe TM. Prevalence of endometriosis diagnosed by laparoscopy in adolescents with dysmenorrhea or chronic pelvic pain: a systematic review. Human Reproduction Update. 2013;19(5):570-582.  https://doi.org/10.1093/humupd/dmt016
  4. Matalliotakis M, Goulielmos GN, Matalliotaki C, Trivli A, Matalliotakis I, Arici A. Endometriosis in Adolescent and Young Girls: Report on a Series of 55 Cases. Journal of Pediatric and Adolescent Gynecology. 2017;30(5):568-570.  https://doi.org/10.1016/j.jpag.2017.05.007
  5. Alimi Y, Iwanaga J, Loukas M, Tubbs RS. The clinical anatomy of endometriosis: A review. Cureus. 2018;10(9):e3361. https://doi.org/10.7759/cureus.3361
  6. Machairiotis N, Stylianaki A, Dryllis G, Zarogoulidis P, Kouroutou P, Tsiamis N, Katsikogiannis N, Sarika E, Courcoutsakis N, Tsiouda T, Gschwendtner A, Zarogoulidis K, Sakkas L, Baliaka A, Machairiotis C. Extrapelvic endometriosis: a rare entity or an under-diagnosed condition? Diagnostic Pathology. 2013;8:194.  https://doi.org/10.1186/1746-1596-8-194
  7. Haas D, Chvatal R, Reichert B, Renner S, Shebl O, Binder H, Wurm P, Oppelt P. Endometriosis: a premenopausal disease? Age pattern in 42,079 patients with endometriosis. Archives of Gynecology and Obstetrics. 2012;286(3):667-670.  https://doi.org/10.1007/s00404-012-2361-z
  8. Ueda Y, Enomoto T, Miyatake T, Fujita M, Yamamoto R, Kanagawa T, Shimizu H, Kimura T. A retrospective analysis of ovarian endometriosis during pregnancy. Fertility and Sterility. 2010;94(1): 78-84.  https://doi.org/10.1016/j.fertnstert.2009.02.092
  9. Yuan P, Huang Y, Cheng B, Zhang J, Xin X. Induction of a local pseudo-pregnancy for the treatment of endometriosis. Medical Hypotheses. 2010;74(1):56-58.  https://doi.org/10.1016/j.mehy.2009.08.001
  10. Farland LV, Eliassen AH, Tamimi RM, Spiegelman D, Michels KB, Missmer SA. History of breast feeding and risk of incident endometriosis: prospective cohort study. British Medical Journal. 2017; 358:j3778. https://doi.org/10.1136/bmj.j3778
  11. Kistner RW. The use of newer progestins in the treatment of endometriosis. American Journal of Obstetrics and Gynecology. 1958;75(2): 264-278.  https://doi.org/10.1016/0002-9378(58)90384-3
  12. Brown J, Farquhar C. An overview of treatments for endometriosis. JAMA: The Journal of the American Medical Association. 2015;313: 296-297.  https://doi.org/10.1001/jama.2014.17119
  13. Zondervan KT, Becker CM, Koga K, Missmer SA, Taylor RN, Viganò P. Endometriosis. Nature Reviews. Disease Primers. 2018;4(1):9.  https://doi.org/10.1038/s41572-018-0008-5
  14. Mahoney MM. Shift work, jet lag, and female reproduction. International Journal of Endocrinology. 2010;813764. https://doi.org/10.1155/2010/813764
  15. Linde VA, Ermolova NV, Slesareva KV, Drukker NA, Markaryan IV. The clinical significance of melatonin in the development and progression of external genital endometriosis patients of reproductive age. Glavnyj vrach Yuga Rossii. 2016;50(3):18-20. (In Russ.).
  16. Yarmolinskaya MI, Zaytsev DV, Tkhazaplizheva SSh. Melatonin and genital endometriosis — new possibilities of therapy. Zhurnal akusherstva i zhenskikh boleznej. 2015;64(1):67-75. (In Russ.). https://doi.org/10.17816/JOWD64167-75
  17. Yarmolinskaya MI, Tkhazaplizheva SSh, Molotkov AS, Tkachenko NN, Borodina VL, Andreeva NYu, Kleymenova TS, Lysenko VV. Genital endometriosis and melatonin: a role in the pathogenesis and its possible use in the treatment of the disease. Zhurnal akusherstva i zhenskikh boleznej. 2019;68(3):51-60. (In Russ.). https://doi.org/10.17816/JOWD68351-60
  18. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr, Lee DH, Shioda T, Soto AM, vom Saal FS, Welshons WV, Zoeller RT, Myers JP. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocrine Reviews. 2012;33(3):378-455.  https://doi.org/10.1210/er.2011-1050
  19. Rysavy NM, Maaetoft-Udsen K, Turner H. Dioxins: diagnostic and prognostic challenges arising from complex mechanisms. Journal of Applied Toxicology: JAT. 2013;33(1):1-8.  https://doi.org/10.1002/jat.2759
  20. Lorber M, Patterson D, Huwe J, Kahn H: Evaluation of background exposures of Americans to dioxin-like compounds in the 1990s and the 2000s. Chemosphere. 2009;77(5):640-651.  https://doi.org/10.1016/j.chemosphere.2009.08.016
  21. Bruner-Tran KL, Ding T, Osteen KG. Dioxin and endometrial progesterone resistance. Seminars in Reproductive Medicine. 2010; 28(1):59-68.  https://doi.org/10.1055/s-0029-1242995
  22. Sofo V, Götte M, Laganà AS, Salmeri FM, Triolo O, Sturlese E, Retto G, Alfa M, Granese R, Abrão MS. Correlation between dioxin and endometriosis: an epigenetic route to unravel the pathogenesis of the disease. Archives of Gynecology and Obstetrics. 2015; 292(5):973-986.  https://doi.org/10.1007/s00404-015-3739-5
  23. Eisenberg VH, Zolti M, Soriano D. Is there an association between autoimmunity and endometriosis? Autoimmunity Reviews. 2012;11(1): 806-814.  https://doi.org/10.1016/j.autrev.2012.01.005
  24. Sundqvist J, Falconer H, Seddighzadeh M, Vodolazkaia A, Fassbender A, Kyama C, Bokor A, Stephansson O, Padyukov L, Gemzell-Danielsson K, D’Hooghe TM. Endometriosis and autoimmune disease: association of susceptibility to moderate/severe endometriosis with CCL21 and HLA-DRB1. Fertility and Sterility. 2011;95(1): 437-440.  https://doi.org/10.1016/j.fertnstert.2010.07.1060
  25. Jess T, Frisch M, Jorgensen KT, Pedersen BV, Nielsen NM. Increased risk of inflammatory bowel disease in women with endometriosis: a nationwide Danish cohort study. Gut. 2012;61(9):1279-1283. https://doi.org/10.1136/gutjnl-2011-301095
  26. Inagaki J, Hao L, Nakatsuka M, Yasuda T, Hiramatsu Y, Shoenfeld Y, Matsuura E. A possible mechanism of autoimmune-mediated infertility in women with endometriosis. American Journal of Reproductive Immunology. 2011;66(2):90-99.  https://doi.org/10.1111/j.1600-0897.2010.00956.x
  27. Sampson J. The development of the implantation theory for the origin of peritoneal endometriosis. International Journal of Advanced Research. 1940;40:549-556.  https://doi.org/10.21474/IJAR01/10445
  28. Meyer R. Über den Stand der Frage der adenomyositis und adenomyoma im allgemeinem und insbesondere über adenomyositis serosoepithelialis und adenomyometritis sarcomatosa. Zentral Bibliothek Gynaecologie. 1919;43:745-750. 
  29. Gargett CE, Schwab KE, Deane JA. Endometrial stem/progenitor cells: the first 10 years. Human Reproduction Update. 2016;22(2):137-163.  https://doi.org/10.1093/humupd/dmv051
  30. Yang J, Huang F. Stem cell and endometriosis: new knowledge may be producing novel therapies. International Journal of Clinical and Experimental Medicine. 2014;7(11):3853-3858.
  31. Jerman LF, Hey-Cunningham AJ. The role of the lymphatic system in endometriosis: A comprehensive review of the literature. Biology of Reproduction. 2015;92(3):64.  https://doi.org/10.1095/biolreprod.114.124313
  32. Agarwal N, Subramanian A. Endometriosis — morphology, clinical presentations and molecular pathology. Journal of Laboratory Physicians. 2010;2(1):1-9.  https://doi.org/10.4103/0974-2727.66699
  33. Casey L, Singh N. Metastases to the ovary arising from endometrial, cervical and fallopian tube cancer: recent advances. Histopathology. 2020;76(1):37-51.  https://doi.org/10.1111/his.13985
  34. Burney RO, Giudice LC. Reprint of: Pathogenesis and pathophysiology of endometriosis. Fertility and Sterility. 2019;112(4S1): 153-161.  https://doi.org/10.1016/j.fertnstert.2019.08.083
  35. Young VJ, Brown JK, Saunders PT, Horne AW. Horne, The role of the peritoneum in the pathogenesis of endometriosis. Human Reproduction Update. 2013;19(5):558-569.  https://doi.org/10.1093/humupd/dmt024
  36. Koninckx PR, Ussia A, Adamyan L, Wattiez A, Gomel V, Martin DC. Pathogenesis of endometriosis: the genetic/epigenetic theory. Fertility and Sterility. 2019;111(2):327-340.  https://doi.org/10.1016/j.fertnstert.2018.10.013
  37. Ferrero S, Evangelisti G, Barra F. Current and emerging treatment options for endometriosis. Expert Opinion on Pharmacotherapy. 2018; 19(10):1109-1125. https://doi.org/10.1080/14656566.2018.1494154
  38. Han SJ, Jung SY, Wu SP, Hawkins SM, Park MJ, Kyo S, Qin J, Lydon JP, Tsai SY, Tsai MJ, DeMayo FJ, O’Malley BW. Estrogen receptor beta modulates apoptosis complexes and the inflammasome to drive the pathogenesis of endometriosis. Cell. 2015;163(4):960-974.  https://doi.org/10.1016/j.cell.2015.10.034
  39. Leyendecker G, Wildt L. A new concept of endometriosis and adenomyosis: tissue injury and repair (TIAR). Hormone Molecular Biology and Clinical Investigation. 2011;5(2):125-142.  https://doi.org/10.1515/HMBCI.2011.002
  40. Gellersen B, Brosens JJ. Cyclic Decidualization of the Human Endometrium in Reproductive Health and Failure. Endocrine Reviews. 2014;35(6):851-905.  https://doi.org/10.1210/er.2014-1045
  41. Matsuzaki S, Maleysson E, Darcha C. Analysis of matrix metalloproteinase-7 expression in eutopic and ectopic endometrium samples from patients with different forms of endometriosis. Human Reproduction. 2010;25(3):742-750.  https://doi.org/10.1093/humrep/dep435
  42. Konrad L, Dietze R, Kudipudi PK, Horné F, Meinhold-Heerlein I. Endometriosis in MRKH cases as a proof for the coelomic metaplasia hypothesis? Reproduction. 2019;158(2):41-47.  https://doi.org/10.1530/REP-19-0106
  43. Fukunaga M. Paratesticular endometriosis in a man with a prolonged hormonal therapy for prostatic carcinoma. Pathology, Research and Practice. 2012;208(1):59-61.  https://doi.org/10.1016/j.prp.2011.10.007
  44. Nerune SM, Hippargi SB, Mestri NB, Mehrotra NM. Persistent Mullerian Duct Syndrome with Ovarian Endometriosis — A Rare Case Report. Journal of Clinical and Diagnostic Research: JCDR. 2016;10(2):ED14-5.  https://doi.org/10.7860/JCDR/2016/16691.7266
  45. Matsuzaki S, Darcha C. Epithelial to mesenchymal transition-like and mesenchymal to epithelial transition-like processes might be involved in the pathogenesis of pelvic endometriosis. Human Reproduction. 2012;27(3):712-721.  https://doi.org/10.1093/humrep/der442
  46. Bouquet de Jolinière J, Ayoubi JM, Lesec G, Validire P, Goguin A, Gianaroli L, Dubuisson JB, Feki A, Gogusev J. Identification of displaced endometrial glands and embryonic duct remnants in female fetal reproductive tract: Possible pathogenetic role in endometriotic and pelvic neoplastic processes. Frontiers in Physiology. 2012;3:444.  https://doi.org/10.3389/fphys.2012.00444
  47. Levander G, Normann P. The pathogenesis of endometriosis; an experimental study. Acta Obstetricia et Gynecologica Scandinavica. 1955;34(4):366-398.  https://doi.org/10.3109/00016345509158287
  48. Koninckx PR, Ussia A, Keckstein J, Wattiez A, Adamyan L. Epidemiology of subtle, typical, cystic, and deep endometriosis: a systematic review. Gynecological Surgery. 2016;13:457-467.  https://doi.org/10.1007/s10397-016-0970-4
  49. Rahmioglu N, Montgomery GW, Zondervan KT. Genetics of endometriosis. Women’s Health. 2015;11(5):577-586.  https://doi.org/10.2217/whe.15.41
  50. Bouquet De Jolinière J, Ayoubi JM, Gianaroli L, Dubuisson JB, Gogusev J, Feki A. Endometriosis: a new cellular and molecular genetic approach for understanding the pathogenesis and evolutivity. Frontiers in Surgery. 2014;1:16.  https://doi.org/10.3389/fsurg.2014.00016
  51. Sapkota Y, Steinthorsdottir V, Morris AP, Fassbender A, Rahmioglu N, De Vivo I, Buring JE, Zhang F, Edwards TL, Jones S, O D, Peterse D, Rexrode KM, Ridker PM, Schork AJ, MacGregor S, Martin NG, Becker CM, Adachi S, Yoshihara K, Enomoto T, Takahashi A, Kamatani Y, Matsuda K, Kubo M, Thorleifsson G, Geirsson RT, Thorsteinsdottir U, Wallace LM; iPSYCH-SSI-Broad Group, Yang J, Velez Edwards DR, Nyegaard M, Low SK, Zondervan KT, Missmer SA, D’Hooghe T, Montgomery GW, Chasman DI, Stefansson K, Tung JY, Nyholt DR. Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism. Nature Communications. 2017;8:15539. https://doi.org/10.1038/ncomms15539
  52. Figueira PG, Abrão MS, Krikun G, Taylor HS. Stem cells in endometrium and their role in the pathogenesis of endometriosis. Annals of the New York Academy of Sciences. 2011;1221(1):10-17.  https://doi.org/10.1111/j.1749-6632.2011.05969.x
  53. Cervelló I, Gil-Sanchis C, Mas A, Delgado-Rosas F, Martínez-Conejero JA, Galán A, Martínez-Romero A, Martínez S, Navarro I, Ferro J, Horcajadas JA, Esteban FJ, O’Connor JE, Pellicer A, Simón C. Human endometrial side population cells exhibit genotypic, phenotypic and functional features of somatic stem cells. PLoS One. 2010;24;5(6):e10964. https://doi.org/10.1371/journal.pone.0010964
  54. Gargett CE, Ye L. Endometrial reconstruction from stem cells. Fertility and Sterility. 2012;98(1):11-20.  https://doi.org/10.1016/j.fertnstert.2012.05.004
  55. Wang H, Jin P, Sabatino M, Ren J, Civini S, Bogin V, Ichim TE, Stroncek DF. Comparison of endometrial regenerative cells and bone marrow stromal cells. Journal of Translational Medicine. 2012; 10:207.  https://doi.org/10.1186/1479-5876-10-207
  56. Du X, Yuan Q, Qu Y, Zhou Y, Bei J. Endometrial mesenchymal stem cells isolated from menstrual blood by adherence. Stem Cells International. 2016;3573846. https://doi.org/10.1155/2016/3573846
  57. Alcayaga-Miranda F, Cuenca J, Luz-Crawford P, Aguila-Díaz C, Fernandez A, Figueroa FE, Khoury M. Characterization of menstrual stem cells: angiogenic effect, migration and hematopoietic stem cell support in comparison with bone marrow mesenchymal stem cells. Stem Cell Research and Therapy. 2015;6(1):32.  https://doi.org/10.1186/s13287-015-0013-5
  58. Ikegami Y, Miyoshi S, Nishiyama N, Hida N, Okamoto K, Miyado K, Segawa K, Ogawa S, Umezawa A. Serum-independent cardiomyogenic transdifferentiation in human endometrium-derived mesenchymal cells. Artificial Organs. 2010;34(4):280-288.  https://doi.org/10.1111/j.1525-1594.2009.00859.x
  59. Mou XZ, Lin J, Chen JY, Li YF, Wu XX, Xiang BY, Li CY, Ma JM, Xiang C. Menstrual blood-derived mesenchymal stem cells differentiate into functional hepatocyte-like cells. Journal of Zhejiang University. Science. B. 2013;14(11):961-972.  https://doi.org/10.1631/jzus.B1300081
  60. Alcayaga-Miranda F, Cuenca J, Martin A, Contreras L, Figueroa FE, Khoury M. Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival in sepsis. Stem Cell Research and Therapy. 2015;6:199.  https://doi.org/10.1186/s13287-015-0192-0
  61. Luz-Crawford P, Torres MJ, Noël D, Fernandez A, Toupet K, Alcayaga-Miranda F, Tejedor G, Jorgensen C, Illanes SE, Figueroa FE, Djouad F, Khoury M. The immunosuppressive signature of menstrual blood mesenchymal stem cells entails opposite effects on experimental arthritis and graft versus host diseases. Stem Cells. 2016;34(2):456-469.  https://doi.org/10.1002/stem.2244
  62. Ulrich D, Muralitharan R, Gargett CE. Toward the use of endometrial and menstrual blood mesenchymal stem cells for cell-based therapies. Expert Opinion on Biological Therapy. 2013;13(10): 1387-1400. https://doi.org/10.1517/14712598.2013.826187
  63. Khoury M, Alcayaga-Miranda F, Illanes SE, Figueroa FE. The promising potential of menstrual stem cells for antenatal diagnosis and cell therapy. Frontiers in Immunology. 2014;5:205.  https://doi.org/10.3389/fimmu.2014.00205
  64. Vercellini P, Vigano P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nature Reviews. Endocrinology. 2014; 10(5):261-275.  https://doi.org/10.1038/nrendo.2013.255
  65. Klemmt PAB, Starzinski-Powitz A. Molecular and Cellular Pathogenesis of Endometriosis. Current Women’s Health Reviews. 2018; 14(2):106-116.  https://doi.org/10.2174/1573404813666170306163448
  66. Sanchez AM, Viganò P, Somigliana E, Panina-Bordignon P, Vercellini P, Candiani M. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Human Reproduction Update. 2014;20(2):217-230.  https://doi.org/10.1093/humupd/dmt053
  67. Tosti C, Pinzauti S, Santulli P, Chapron C, Petraglia F. Pathogenetic mechanisms of deep infiltrating endometriosis. Reproductive Sciences. 2015;22(9):1053-1059. https://doi.org/10.1177/1933719115592713
  68. Gordts S, Koninckx P, Brosens I. Pathogenesis of deep endometriosis. Fertility and Sterility. 2017;108(6):872-886.  https://doi.org/10.1016/j.fertnstert.2017.08.036
  69. Ahmad SF, Michaud N, Rakhila H, Akoum A. Macrophages in Pathophysiology of Endometriosis. In: Harada T, ed. Endometriosis. Pathogenesis and Treatment. Tokyo: Springer; 2014.
  70. Parkin KL, Fazleabas AT. Uterine leukocyte function and dysfunction: a hypothesis on the impact of endometriosis. American Journal of Reproductive Immunology. 2016;75(3):411-417.  https://doi.org/10.1111/aji.12487
  71. Monsanto SP, Edwards AK, Zhou J, Nagarkatti P, Nagarkatti M, Young SL, Lessey BA, Tayade C. Surgical removal of endometriotic lesions alters local and systemic proinflammatory cytokines in endometriosis patients. Fertility and Sterility. 2016;105(4):968-977.  https://doi.org/10.1016/j.fertnstert.2015.11.047
  72. Olovsson M. Immunological aspects of endometriosis: an update. American Journal of Reproductive Immunology. 2011;66(Suppl 1):101-104.  https://doi.org/10.1111/j.1600-0897.2011.01045.x
  73. Laschke MW, Menger MD. The gut microbiota: a puppet master in the pathogenesis of endometriosis? American Journal of Obstetrics and Gynecology. 2016;215(1):68.e1-4.  https://doi.org/10.1016/j.ajog.2016.02.036
  74. Nothnick W, Alali Z. Recent advances in the understanding of endometriosis: the role of inflammatory mediators in disease pathogenesis and treatment. F1000Research. 2016;17:5.  https://doi.org/10.12688/f1000research.7504.1
  75. Benagiano G, Habiba M, Brosens I. The pathophysiology of uterine adenomyosis: an update. Fertility and Sterility. 2012;98(3):572-579.  https://doi.org/10.1016/j.fertnstert.2012.06.044
  76. Adachi M, Nasu K, Tsuno A, Yuge A, Kawano Y, Narahara H. Attachment to extracellular matrices is enhanced in human endometriotic stromal cells: a possible mechanism underlying the pathogenesis of endometriosis. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2011;155(1):85-88.  https://doi.org/10.1016/j.ejogrb.2010.10.026
  77. Kasvandik S, Samuel K, Peters M, Eimre M, Peet N, Roost AM, Padrik L, Paju K, Peil L, Salumets A. Deep quantitative proteomics reveals extensive metabolic reprogramming and cancer like changes of ectopic endometriotic stromal cells. Journal of Proteome Research. 2016;15(2):572-584.  https://doi.org/10.1021/acs.jproteome.5b00965
  78. Guo S-W. Epigenetics of endometriosis. Molecular Human Reproduction. 2009;15(10):587-607.  https://doi.org/10.1093/molehr/gap064
  79. Nasu K, Kawano Y, Kai K, Aoyagi Y, Abe W, Okamoto M, Narahara H. Aberrant histone modification in endometriosis. Frontiers in Bioscience. 2014;19:1202-1214. https://doi.org/10.2741/4276
  80. Teague EM, Print CG, Hull ML. The role of microRNAs in endometriosis and associated reproductive conditions. Human Reproduction Update. 2010;16(2):142-165.  https://doi.org/10.1093/humupd/dmp034
  81. Lv JW, Wen W, Jiang C, Fu QB, Gu YJ, Lv TT, Li ZD, Xue W. Inhibition of microRNA-214 promotes epithelial-mesenchymal transition process and induces interstitial cystitis in postmenopausal women by upregulating Mfn2. Experimental and Molecular Medicine. 2017;49(7):e357. https://doi.org/10.1038/emm.2017.98
  82. Wu D, Lu P, Mi X, Miao J. Exosomal miR-214 from endometrial stromal cells inhibits endometriosis fibrosis. Molecular Human Reproduction. 2018;24(7):357-365.  https://doi.org/10.1093/molehr/gay019
  83. Zhao ZZ, Croft L, Nyholt DR, Chapman B, Treloar SA, Hull ML, Montgomery GW. Evaluation of polymorphisms in predicted target sites for micro RNAs differentially expressed in endometriosis. Molecular Human Reproduction. 2011;17(2):92-103.  https://doi.org/10.1093/molehr/gaq084
  84. Saare M, Rekker K, Laisk-Podar T, Rahmioglu N, Zondervan K, Salumets A, Götte M, Peters M. Challenges in endometriosis miRNA studies — From tissue heterogeneity to disease specific miRNAs. Biochimica et Biophysica Acta Molecular Basis of Disease. 2017; 1863(9):2282-2292. https://doi.org/10.1016/j.bbadis.2017.06.018
  85. Panir K, Schjenken JE, Robertson SA, Hull ML. Non-coding RNAs in endometriosis: A narrative review. Human Reproduction Update. 2018;24(4):497-515.  https://doi.org/10.1093/humupd/dmy014
  86. Khalaj K, Miller JE, Lingegowda H, Fazleabas AT, Young SL, Lessey BA, Koti M, Tayade C. Extracellular vesicles from endometriosis patients are characterized by a unique miRNA-lncRNA signature. JCI Insight. 2019;19;4(18):e128846. https://doi.org/10.1172/jci.insight.128846
  87. Bjorkman S, Taylor HS. Erratum: MicroRNAs in endometriosis biological function and emerging biomarker candidates. Biology of Reproduction. 2019;101(6):1179. https://doi.org/10.1093/biolre/ioz219
  88. Jichan Nie, Xishi Liu, Guo SW. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent. Reproductive Sciences. 2010;17(11):995-1005. https://doi.org/10.1177/1933719110377118
  89. Bulun SE, Yilmaz BD, Sison C, Miyazaki K, Bernardi L, Liu S, Kohlmeier A, Yin P, Milad M, Wei J. Endometriosis. Endocrine Reviews. 2019;40(4):1048-1079. https://doi.org/10.1210/er.2018-00242
  90. Forte A, Cipollaro M, Galderisi U. Genetic, epigenetic and stem cell alterations in endometriosis: new insights and potential therapeutic perspectives. Clinical Science. 2014;126(2):123-138.  https://doi.org/10.1042/CS20130099
  91. Uimari O, Rahmioglu N, Nyholt DR, Vincent K, Missmer SA, Becker C, Morris AP, Montgomery GW, Zondervan KT. Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis. Human Reproduction. 2017;32(4):780-793.  https://doi.org/10.1093/humrep/dex024
  92. Painter JN, O’Mara TA, Morris AP, Cheng THT, Gorman M, Martin L, Hodson S, Jones A, Martin NG, Gordon S, Henders AK, Attia J, McEvoy M, Holliday EG, Scott RJ, Webb PM, Fasching PA, Beckmann MW, Ekici AB, Hein A, Rübner M, Hall P, Czene K, Dörk T, Dürst M, Hillemanns P, Runnebaum I, Lambrechts D, Amant F, Annibali D, Depreeuw J, Vanderstichele A, Goode EL, Cunningham JM, Dowdy SC, Winham SJ, Trovik J, Hoivik E, Werner HMJ, Krakstad C, Ashton K, Otton G, Proietto T, Tham E, Mints M, Ahmed S, Healey CS, Shah M, Pharoah PDP, Dunning AM, Dennis J, Bolla MK, Michailidou K, Wang Q, Tyrer JP, Hopper JL, Peto J, Swerdlow AJ, Burwinkel B, Brenner H, Meindl A, Brauch H, Lindblom A, Chang-Claude J, Couch FJ, Giles GG, Kristensen VN, Cox A, Zondervan KT, Nyholt DR, MacGregor S, Montgomery GW, Tomlinson I, Easton DF, Thompson DJ, Spurdle AB. Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. Cancer Medicine. 2018;7(5):1978-1987. https://doi.org/10.1002/cam4.1445
  93. Raposo G, Stoorvogel W. Extracellular vesicles: Exosomes, microvesicles and friends. The Journal of Cell Biology. 2013;200(4): 373-383.  https://doi.org/10.1083/jcb.201211138
  94. Braicu C, Tomuleasa C, Monroig P, Cucuianu A, Berindan-Neagoe I, Calin GA. Exosomes as divine messengers: are they the Hermes of modern molecular oncology? Cell Death and Differentiation. 2015; 22(1):34-45.  https://doi.org/10.1038/cdd.2014.130
  95. Ng YH, Rome S, Jalabert A, Forterre A, Singh H, Hincks CL, Salamonsen LA. Endometrial exosomes/microvesicles in the uterine microenvironment: A new paradigm for embryo-endometrial cross talk at implantation. PLoS One. 2013;8(3):e58502. https://doi.org/10.1371/journal.pone.0058502
  96. Aznaurova YB, Zhumataev MB, Roberts TK, Aliper AM, Zhavoronkov AA. Molecular aspects of development and regulation of endometriosis. Reproductive Biology and Endocrinology: RB&E. 2014; 12:50.  https://doi.org/10.1186/1477-7827-12-50
  97. May KE, Conduit-Hulbert SA, Villar J, Kirtley S, Kennedy SH, Becker CM. Peripheral biomarkers of endometriosis: A systematic review. Human Reproduction Update. 2010;16(6):651-674.  https://doi.org/10.1093/humupd/dmq009
  98. Texidó L, Romero C, Vidal A, García-Valero J, Fernández Montoli ME, Baixeras N, Condom E, Ponce J, García-Tejedor A, Martín-Satué M. Ecto-nucleotidases activities in the contents of ovarian endometriomas: Potential biomarkers of endometriosis. Mediators of Inflammation. 2014;120673. https://doi.org/10.1155/2014/120673
  99. Harp D, Driss A, Mehrabi S, Chowdhury I, Xu W, Liu D, Garcia-Barrio M, Taylor RN, Gold B, Jefferson S, Sidell N, Thompson W. Exosomes derived from endometriotic stromal cells have enhanced angiogenic effects in vitro. Cell and Tissue Research. 2016;365(1): 187-196.  https://doi.org/10.1007/s00441-016-2358-1
  100. Qiu JJ, Lin XJ, Zheng TT, Tang XY, Zhang Y, Hua KQ. The exosomal long noncoding RNA aHIF is upregulated in serum from patients with endometriosis and promotes angiogenesis in endometriosis. Reproductive Sciences. 2019;26(12):1590-1602. https://doi.org/10.1177/1933719119831775
  101. Sun H, Li D, Yuan M, Li Q, Li N, Wang G. Eutopic stromal cells of endometriosis promote neuroangiogenesis via exosome pathway. Biology of Reproduction. 2019;100(3):649-659.  https://doi.org/10.1093/biolre/ioy212
  102. Braza-Boïls A, Salloum-Asfar S, Marí-Alexandre J, Arroyo AB, González-Conejero R, Barceló-Molina M, García-Oms J, Vicente V, Estellés A, Gilabert-Estellés J, Martínez C. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis. Human Reproduction. 2015;30(10):2292-2302. https://doi.org/10.1093/humrep/dev204
  103. Pabona JM, Simmen FA, Nikiforov MA, Zhuang D, Shankar K, Velarde MC, Zelenko Z, Giudice LC, Simmen RC. Kruppel-like factor 9 and progesterone receptor coregulation of decidualizing endometrial stromal cells: implications for the pathogenesis of endometriosis. The Journal of Clinical Endocrinology and Metabolism. 2012;97(3):376-92.  https://doi.org/10.1210/jc.2011-2562
  104. Zelenko Z, Aghajanova L, Irwin JC, Giudice LC. Nuclear receptor, coregulator signaling, and chromatin remodeling pathways suggest involvement of the epigenome in the steroid hormone response of endometrium and abnormalities in endometriosis. Reproductive Sciences. 2012;19(2):152-162.  https://doi.org/10.1177/1933719111415546
  105. Aghajanova L, Giudice LC. Molecular evidence for differences in endometrium in severe versus mild endometriosis. Reproductive Sciences. 2011;18(3):229-251.  https://doi.org/10.1177/1933719110386241
  106. Lobb RJ, Lima LG, Möller A. Exosomes: key mediators of metastasis and pre-metastatic niche formation. Seminars in Cell and Developmental Biology. 2017;67:3-10.  https://doi.org/10.1016/j.semcdb.2017.01.004
  107. Sun H, Li D, Yuan M, Li Q, Zhen Q, Li N, Wang G. Macrophages alternatively activated by endometriosis-exosomes contribute to the development of lesions in mice. Molecular Human Reproduction. 2019;25(1):5-16.  https://doi.org/10.1093/molehr/gay049
  108. Schjenken JE, Panir K, Robertson SA, Hull ML. Exosome-mediated intracellular signaling impacts the development of endometriosis — new avenues for endometriosis research. Molecular Human Reproduction. 2019;25(1):2-4.  https://doi.org/10.1093/molehr/gay050
  109. Nawaz M, Shah N, Zanetti BR, Maugeri M, Silvestre RN, Fatima F, Neder L, Valadi H. Extracellular vesicles and matrix remodeling enzymes: The emerging roles in extracellular matrix remodeling, progression of diseases and tissue repair. Cells. 2018;7(10):167.  https://doi.org/10.3390/cells7100167
  110. Filigheddu N, Gregnanin I, Porporato PE, Surico D, Perego B, Galli L, Patrignani C, Graziani A, Surico N. Differential Expression of MicroRNAs between Eutopic and Ectopic Endometrium in Ovarian Endometriosis. Journal of Biomedicine and Biotechnology. 2010;369549. https://doi.org/10.1155/2010/369549
  111. Chappell WH, Steelman LS, Long JM, Kempf RC, Abrams SL, Franklin RA, Bäsecke J, Stivala F, Donia M, Fagone P, Malaponte G, Mazzarino MC, Nicoletti F, Libra M, Maksimovic-Ivanic D, Mijatovic S, Montalto G, Cervello M, Laidler P, Milella M, Tafuri A, Bonati A, Evangelisti C, Cocco L, Martelli AM, McCubrey JA. Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health. Oncotarget. 2011;2(3):135-164.  https://doi.org/10.18632/oncotarget.240
  112. Malhotra N, Kang J. SMAD regulatory networks construct a balanced immune system. Immunology. 2013;139(1):1-10.  https://doi.org/10.1111/imm.12076
  113. Young VJ, Ahmad SF, Duncan WC, Horne AW. The role of TGF-β in the pathophysiology of peritoneal endometriosis. Human Reproduction Update. 2017;23(5):548-559.  https://doi.org/10.1093/humupd/dmx016
  114. McKinnon BD, Kocbek V, Nirgianakis K, Bersinger NA, Mueller MD. Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics. Human Reproduction Update. 2016;22(3):382-403.  https://doi.org/10.1093/humupd/dmv060
  115. MacDonald BT, He X. A finger on the pulse of Wnt receptor signaling. Cell Research. 2012;22(10):1410-1412. https://doi.org/10.1038/cr.2012.91
  116. Serrano-Gomez SJ, Maziveyi M, Alahari SK. Regulation of epithelial-mesenchymal transition through epigenetic and posttranslational modifications. Molecular Cancer. 2016;15:18.  https://doi.org/10.1186/s12943-016-0502-x
  117. Schuijers J, Mokry M, Hatzis P, Cuppen E, Clevers H. Wnt-induced transcriptional activation is exclusively mediated by TCF/LEF. The EMBO Journal. 2014;33(2):146-156.  https://doi.org/10.1002/embj.201385358
  118. Xiong W, Zhang L, Yu L, Xie W, Man Y, Xiong Y, Liu H, Liu Y. Estradiol promotes cells invasion by activating β-catenin signaling pathway in endometriosis. Reproduction. 2015;150(6):507-516.  https://doi.org/10.1530/REP-15-0371
  119. Zhang L, Xiong W, Xiong Y, Liu H, Liu Y. 17 beta-Estradiol promotes vascular endothelial growth factor expression via the Wnt/beta-catenin pathway during the pathogenesis of endometriosis. Molecular Human Reproduction. 2016;22(7):526-535.  https://doi.org/10.1093/molehr/gaw025
  120. de Mattos RM, Pereira PR, Barros EG, da Silva JH, Palmero CY, da Costa NM, Pinto LF, Gimba ER, Hecht F, Ferreira LB, Machado DE, de Oliveira FL, Nasciutti LE. Aberrant levels of WNT/beta-catenin pathway components in a rat model of endometriosis. Histology and Histopathology. 2016;31(8):933-942.  https://doi.org/10.14670/HH-11-730
  121. Matsuzaki S, Darcha C. In vitro effects of a small-molecule antagonist of the Tcf/ß-catenin complex on endometrial and endometriotic cells of patients with endometriosis. PLoS One. 2013;8(4):e61690. https://doi.org/10.1371/journal.pone.0061690
  122. Hirakawa T, Nasu K, Miyabe S, Kouji H, Katoh A, Uemura N, Narahara H. β-catenin signaling inhibitors ICG-001 and C-82 improve fibrosis in preclinical models of endometriosis. Scientific Reports. 2019;9(1):20056. https://doi.org/10.1038/s41598-019-56302-4
  123. Fuentes RG, Arai MA, Ishibashi M. Natural compounds with Wnt-signal modulating activity. Natural Product Reports. 2015;32(12): 1622-1628. https://doi.org/10.1039/c5np00074b

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.